North America Craniomaxillofacial Implants Market, By Type (Bone Graft Substitute, Mid-Face Implants, Cranial/Neuro Implants, Mandibular Orthognathic Implants, Distraction System, Cranial Flap Fixation Systems, Patient Specific Implants (PSI), Total Temporomandibular (TMJ) Replacement System, Dural Repair Products, Others), Material of Construction (Metal, Bone Graft Substitute, Polymers/Biomaterial, Others), Application Site (Internal Fixators, External Fixators), Surgery Type (Reconstructive Surgery, Trauma Surgeries, Plastic Surgeries, Orthognathic Surgeries, Dental Surgeries, Ent Surgeries, Others), Property Type (Non-Resorbable Fixators, Resorbable Fixators), End User (Hospitals, Speciality Clinics, Trauma Centres, Ambulatory Surgical Centers (Ascs), Others), Distribution Channel (Direct Tender, Retail Sales), Country (U.S., Canada, Mexico) Industry Trends & Forecast to 2029.
Market Analysis and Insights: North America Craniomaxillofacial Implants Market
North America craniomaxillofacial implants market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.0% in the forecast period of 2022 to 2029 and is expected to reach USD 2,905.22 million by 2029. The increasing technological advancements is the major driver which propelled the demand of the market in the forecast period.
Craniomaxillofacial implants are employed for craniomaxillofacial surgeries. Craniomaxillofacial abnormalities occur during childbirth due to mother's folic acid deficiency or genetic mutations. Facial defects also damage speech, eating, language, and cause dental problems hearing loss. It is generally performed to treat injuries, defects, and diseases in the head, neck, face, jaws, hard and soft tissues of the oral and maxillofacial region.
The increase in geriatric population and rise in prevalence of bowel and bladder cancer are accelerating the growth of the market. The adaptation of advanced technologies in the industry has been stimulated the market growth consequently, the growing demand of patients specific implants in surgeries is likely to drive the market growth in the projected period.
The craniomaxillofacial implants market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.
North America Craniomaxillofacial Implants Market Scope and Market Size
Craniomaxillofacial Implnats market is segmented on the basis of type, material of construction, application site, surgery type, property type, end user and distribution channel.
- On the basis of type, the craniomaxillofacial implants market is segmented into at bone graft substitute, mid-face implants, cranial/neuro implants, mandibular orthognathic implants, distraction system, cranial flap fixation systems, patient specific implants (PSI), total temporomandibular (TMJ) replacement system, dural repair products, and others. In 2022, bone graft substitute segment is expected to dominate the global craniomaxillofacial implants market due to increase in geriatric population globally.
- On the basis of material of construction, the craniomaxillofacial implants market is segmented into metal, bone graft substitute, polymers/biomaterial, and others. In 2022, metal is expected to dominate the global craniomaxillofacial implants market with the increasing technological advancement and healthcare expenditure government.
- On the basis of application site, the craniomaxillofacial implants market is segmented into external fixators and internal fixators. In 2022, external fixators is expected to dominate the global craniomaxillofacial implants market with the increasing product launches and acquisition.
- On the basis of surgery type, the craniomaxillofacial implants market is segmented into reconstructive surgery, trauma surgeries, plastic surgeries, orthognathic surgeries, dental surgeries, ENT surgeries, and others. In 2022, reconstructive surgeries is expected to dominate the global craniomaxillofacial implants market with the increasing number of surgeries and procedures.
- On the basis of property type, the craniomaxillofacial implants market is segmented resorbable fixators and non-resorbable fixators. In 2022, resorbable fixators is expected to dominate the global craniomaxillofacial implants market as they provide better result in lesser complication.
- On the basis of end user, the craniomaxillofacial implants market is segmented hospital, specialty clinics, trauma centers, ambulatory surgical centers (ASCS), and others. In 2022, hospital is expected to dominate the global craniomaxillofacial implants market with the increasing number of patients and surgeries.
- On the basis of distribution channel, the craniomaxillofacial implants market is segmented direct tender and retail sales. In 2022, direct tender is expected to dominate the global craniomaxillofacial implants market as they have all the major products from major market players.
Craniomaxillofacial Implants Market Country Level Analysis
Craniomaxillofacial Implnats market is segmented on the basis of type, material of construction, application site, surgery type, property type, end user and distribution channel.
The countries covered in the craniomaxillofacial implants market report are U.S., Canada, and Mexico.
- In North America, the U.S. is expected to dominate the market due to the presence of major market players.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Increasing Private Sector Funding and Technological Advancements are Boosting the Market Growth of Craniomaxillofacial Implants
Craniomaxillofacial implants market also provides you with detailed market analysis for every country growth in implants industry with impact of advancement, technology and changes in regulatory scenarios. The data is available for historic period 2011 to 2019.
Competitive Landscape and Craniomaxillofacial implants Market Share Analysis
Craniomaxillofacial implants market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to craniomaxillofacial implants market.
Major companies which are dealing in the craniomaxillofacial implants market are Zimmer Biomet, Stryker, Johnson and Johnson Services Inc., Medtronic, KLS Martin Group, Delphos Implants, Osteomed, Anatomics Pty Ltd, Bioplate Inc., Calavera Surgical Design, Innovasis, Integra LifeSciences Holdings Corp., Dimeda Instrumente GmbH, General Implants GmbH, Jeil Medical Corporation, Xilloc Medical BV, Ortho Select GmbH, B. Braun Melsungen AG, MONDEAL Medical Systems GmbH, OssDsign AB, TREU-Instrumente GmbH, Rebstock Instruments GmbH, 3D Systems, Inc., Medartis AG, BIOPORE SURGICALS, AlloSource, Teknimed, Poriferous, 7s Medical AG, Innovation Medical GmbH, Advin Health care, Gesco Healthcare Pvt. Ltd, Auxein Medical Private Limited Renishaw Plc, Ortho Max Manufacturing Company Pvt. Ltd. Vast Ortho, Skulle Implants Corporation., PANTHERA DENTAL, Lucid Implants among others.
- In October 2021, AlloSource announced that they are launching the AlloMend® Extra-Large (XL) Acellular Dermal Matrix (ADM), which is the newest addition to the AlloMend product line. This have increase companies product pipeline.
- On August 2021, Medtronic plc announced its agreement with Intersect ENT a global ear, nose, and throat (ENT) medical technology leader. Medtronic's acquisition of Intersect ENT expands the company's portfolio of products used during ear, nose, and throat procedures.
SKU-